Beijing Huaye Capital Holdings Co.,Ltd (SHSE:600240) signed conditional asset acquisition framework agreement to acquire pharmaceutical distribution and sales business from Chongqing Hengyun Pharmaceutical Co., Ltd for CNY 80 million on June 15, 2018. The consideration is paid in cash. Beijing Huaye Capital Holdings Co.,Ltd (SHSE:600240) cancelled the acquisition of pharmaceutical distribution and sales business from Chongqing Hengyun Pharmaceutical Co., Ltd. on June 15, 2019.